Filing Details

Accession Number:
0001596783-19-000059
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-16 19:21:10
Reporting Period:
2019-07-12
Accepted Time:
2019-07-16 19:21:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612209 Barry Littlejohns C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
President, Biologics & Sdd No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-12 17,500 $18.57 55,218 No 4 M Direct
Common Stock Disposition 2019-07-12 11,700 $53.54 43,518 No 4 F Direct
Common Stock Acquisiton 2019-07-12 6,764 $18.57 50,282 No 4 M Direct
Common Stock Disposition 2019-07-12 4,523 $53.54 45,759 No 4 F Direct
Common Stock Acquisiton 2019-07-12 4,704 $18.57 50,463 No 4 M Direct
Common Stock Disposition 2019-07-12 3,145 $53.54 47,318 No 4 F Direct
Common Stock Acquisiton 2019-07-12 20,244 $20.50 67,562 No 4 M Direct
Common Stock Disposition 2019-07-12 13,904 $53.54 53,658 No 4 F Direct
Common Stock Disposition 2019-07-12 15,840 $53.53 37,818 No 4 S Direct
Common Stock Disposition 2019-07-12 100 $54.29 37,718 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase Common Stock Disposition 2019-07-12 17,500 $0.00 17,500 $18.57
Common Stock Options to purchase Common Stock Disposition 2019-07-12 6,764 $0.00 6,764 $18.57
Common Stock Options to purchase Common Stock Disposition 2019-07-12 4,704 $0.00 4,704 $18.57
Common Stock Options to purchase Common Stock Disposition 2019-07-12 20,244 $0.00 20,244 $20.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-12-11 No 4 M Direct
0 2016-09-09 2022-12-11 No 4 M Direct
0 2022-12-11 No 4 M Direct
0 2024-07-30 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
  2. Includes restricted stock units.
  3. Represents shares sold pursuant to the Rule 10b5-1 trading plan identified in footnote 1.
  4. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $53.16 to $54.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. On December 11, 2012, the reporting person was granted options to purchase 17,500 shares of common stock of the Issuer, which vested and became exercisable in five equal annual installments beginning on December 11, 2013 (S1045).
  6. On December 11, 2012, the reporting person was granted options to purchase shares of common stock of the Issuer, 6,764 of which vested and became exercisable on September 9, 2016 (S1191 and S1148).
  7. On December 11, 2012, the reporting person was granted options to purchase shares of common stock of the Issuer over a five year period, 4,704 of which vested and became exercisable based on satisfaction of certain performance criteria (S1088).
  8. On July 30, 2014, the reporting person was granted options to purchase 20,244 shares of common stock of the Issuer, which vested and became exercisable in four equal annual installments beginning on July 30, 2015 (S1222).